Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2/Phase 3
MORPHEUS
Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery
- NCT03051464 ↗
- Recruiting
- Sir Mortimer B. Davis - Jewish General Hospital
- Deep
We haven't built an HCP commentary report on MORPHEUS (stage II–III rectal cancer; tests no drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on MORPHEUS so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 25 | |
| YouTube | 17 | |
| Podcasts | 16 |
The trial
ClinicalTrials.gov- Official title
- A Phase III Study Testing Two Dose Escalation Strategies to Increase the Population of Complete Responders After Radiation Therapy in the Context of Organ Preservation for Patients With Rectal Cancer
- Phase
- Phase 2/Phase 3
- Status
- Recruiting
- Conditions
- Stage II Rectal Cancer; Organ Preservation; Non-operative Treatment; Rectal Cancer (Stage III); Rectal Cancer Patients
- Interventions
- Complete responders and Non-complete responders; Chemoradiation + EBRT Boost; Chemoradiation + HDRBT Boost
- Arms
- Chemoradiation + EBRT Boost · Experimental
- Chemoradiation + HDRBT Boost · Experimental
- Enrollment
- 131 (estimated)
- Primary outcomes
- TME-free survival
- Sponsor
- Sir Mortimer B. Davis - Jewish General Hospital
- Start
- Apr 25, 2017
- Primary completion
- Jan 2028 (estimated)
- Results posted
- No
- Registry record
- NCT03051464 · updated Jun 30, 2026